|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01332 TOUYUN BIOTECH
Nominal 
0.157 +0.002 (+1.290%) | 2026/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2025/12 HKD(K$) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | |
| Turnover | 35,389 | -3.259% | 71,948 | 152,299 | 198,032 | 323,334 |
| Cost of Sales | (26,273) | 14.067% | (48,994) | (89,495) | (142,036) | (195,706) |
| Gross Profit | 9,116 | -32.713% | 22,954 | 62,804 | 55,996 | 127,628 |
| 2026/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2025/12 HKD(K$) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | (1,066) | (166) | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 310,815 | 758.676% | 47,574 | (88,366) | (272,585) | (199,183) | |
| Taxation | (18) | 63.636% | (11) | 326 | 16 | (3,473) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | 13,735 | -- | -- | -- | |
| Non-controlling Interests | (112,949) | 571.876% | (34,499) | (67) | 3,630 | 4,591 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 197,848 | 1659.744% | 26,799 | (88,107) | (268,939) | (198,065) | |
| 2026/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2025/12 HKD(K$) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | |
| Net Finance Costs / (Income) | 15,279 | 250.999% | 21,161 | 10,026 | 7,292 | 21,553 |
| Depreciation & Amortisation | 10,393 | -3.294% | 22,170 | 29,476 | 36,585 | 33,138 |
| Directors' Emoluments | -- | -- | 7,765 | 7,180 | 7,022 | 7,473 |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| Auditor's Opinion Status | N/A | -- | Disclaimer | Disclaimer | Disclaimer | Unqualified (Modified Report) |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| EPS (cts) | 7.050 | 1662.500% | 0.950 | -3.140 | -9.580 | -7.060 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | (0.011) | (0.018) | 0.001 | (0.009) |
| NBV per share ($) | 0.050 | -- | (0.018) | (0.030) | 0.000 | 0.094 |
| Remarks: | Real time quote last updated: 11/09/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD 197,848 |
| %Change | 1659.744% |
| EPS / (LPS) | HKD 0.071 |
| NBV Per Share ($) | HKD 0.050 |